Who owns SAREPTA THERAPEUTICS INC NOTE 1.250 9/1?
- CUSIP Number: 803607ad2
Tip: Access positions for across all investors
Analyze quarterly positions in Sarepta Therapeutics Inc Note 1.250 9/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sarepta Therapeutics Inc Note 1.250 9/1 stock
Who bought or sold SAREPTA THERAPEUTICS INC NOTE 1.250 9/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wolverine Asset Management | 76M | $77M | 2% | Dec 2023 |
|
| Calamos Advisors | 60M | $60M | 0% | Dec 2023 |
|
| Braidwell | 51M | $52M | 15% | Dec 2023 |
|
| Highbridge Capital Management | 50M | $51B | 61% | Dec 2023 |
|
| Davidson Kempner Capital Management | 45M | $46M | 7% | Dec 2023 |
|
| Readystate Asset Management | 43M | $44M | 54% | Dec 2023 |
|
| Bank of America Corporation | 42M | $42M | -6% | Dec 2023 |
|
| Lazard Asset Management | 40M | $41M | -17% | Dec 2023 |
|
| Tenor Capital Management | 39M | $39B | 10% | Dec 2023 |
|
| D. E. Shaw & Co | 37M | $37M | 28% | Dec 2023 |
|
| Bank Of Montreal | 27M | $28M | -6% | Dec 2023 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 16M | $16M | -2% | Dec 2023 |
|
| Steelhead Partners | 16M | $16B | 100% | Dec 2023 |
|
| Context Capital Management | 15M | $15B | 66583% | Dec 2023 |
|
| Capstone Investment Advisors | 9.0M | $9.2M | -36% | Dec 2023 |
|
| New York State Common Retirement Fund | 8.4M | $8.5M | 153% | Dec 2023 |
|
| Weiss Asset Management LP[1 | 6.3M | $6.3M | 100% | Dec 2023 |
|
| CNH Partners | 5.6M | $5.7M | 100% | Dec 2023 |
|
| SSI Investment Management | 5.4M | $5.5M | -1% | Dec 2023 |
|
| Man Group | 5.3M | $5.4M | -21% | Dec 2023 |
|
| Balyasny Asset Management | 5.0M | $5.1M | 100% | Dec 2023 |
|
| RWC Asset Management | 4.3M | $4.4M | 0% | Dec 2023 |
|
| Shenkman Capital Management | 3.5M | $3.6B | -5% | Dec 2023 |
|
| Amundi | 3.5M | $3.9M | 0% | Dec 2023 |
|
| Wellesley Investment Advisors | 2.8M | $2.8B | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 2.5M | $2.5M | -34% | Dec 2023 |
|
| Palisade Capital Management | 2.1M | $2.1M | 0% | Dec 2023 |
|
| Edmond De Rothschild Holding | 1.9M | $1.9M | 0% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 1.8M | $1.8M | 100% | Dec 2023 |
|
| Agf Management | 1.7M | $1.7M | 0% | Dec 2023 |
|
| Bank of New York Mellon | 900k | $1.1M | 0% | Mar 2024 |
|
| Wells Fargo & Company | 875k | $889k | 92% | Dec 2023 |
|
| Groupama Asset Managment | 800k | $814k | 100% | Dec 2023 |
|
| Zurcher Kantonalbank | 650k | $756k | -13% | Mar 2024 |
|
| Barclays | 516k | $524k | 100% | Dec 2023 |
|
| Russell Investments | 451k | $459k | -12% | Dec 2023 |
|
| Citigroup | 118k | $119k | -48% | Dec 2023 |
|
| First Hawaiian Bank | 109k | $127k | 0% | Mar 2024 |
|
| Calamos Wealth Management | 55k | $56k | -29% | Dec 2023 |
|
| SG Americas Securities | 39k | $3.9M | 0% | Dec 2023 |
|
| Aurum Wealth Management Group | 17k | $17k | 100% | Dec 2023 |
|
| Candriam Luxembourg S.C.A. | 600.00 | $612k | 100% | Dec 2023 |
|
Who sold out of Sarepta Therapeutics Inc Note 1.250 9/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Graham Capital Management | Sep 2023 | 18M | $20M |
| Royal Bank of Canada | Sep 2023 | 8.8M | $9.9M |
| Lord, Abbett & Co | Sep 2023 | 5.3M | $5.9M |
| Whitebox Advisors | Sep 2023 | 5.0M | $5.6M |
| 683 Capital Management | Sep 2023 | 3.0M | $3.4M |
| Aviva | Sep 2023 | 3.0M | $3.4M |
| Alberta Investment Management Corporation | Sep 2023 | 2.5M | $2.8M |
| Millennium Management | Sep 2023 | 2.0M | $2.2M |
| Skaana Management | Sep 2023 | 2.0M | $2.2M |
| Nicholas Investments Partners | Sep 2023 | 1.9M | $2.1M |
| Nomura Holdings | Sep 2023 | 59k | $7.0M |